Inhibition of SARS-CoV-2 infection in cellular systems using engineered trimeric receptor-binding domain of spike protein

被引:0
|
作者
Liu, Angela Rose [1 ]
Basavarajappa, Shrikanth C. [1 ]
Sarkar, Nandini [1 ]
Bruchez, Anna [1 ]
Ramakrishnan, Parameswaran [1 ,2 ,3 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
来源
STAR PROTOCOLS | 2023年 / 4卷 / 01期
关键词
Cell-based Assays; Health Sciences; Immunology; Molecular Biology; Protein Biochemistry; Protein expression and purification;
D O I
10.1016/j.xpro.2023.102127
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Here, we provide a protocol for the design, expression, purification, and func-tional studies of an engineered trimeric version of the receptor-binding domain (tRBD) of SARS-CoV-2 spike protein. We describe the use of tRBD to block SARS-CoV-2 spike pseudovirus and true virus binding to cellular angiotensin converting enzyme-2 (ACE2), thereby blocking viral infection. This protocol is applicable to generate a trimeric version of any protein of interest.For complete details on the use and execution of this protocol, please refer to Basavarajappa et al. (2022).1
引用
收藏
页数:21
相关论文
共 50 条
  • [41] A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein
    Zhang, Yuting
    Wang, Dan
    Xiang, Qi
    Hu, Xiaohui
    Zhang, Yuting
    Wu, Lijie
    Zhang, Zhaoyong
    Wang, Yanqun
    Zhao, Jincun
    McCormick, Peter J.
    Fu, Jinheng
    Fu, Yang
    Zhang, Jin
    Jiang, Haihai
    Li, Jian
    VIROLOGY, 2024, 589
  • [42] Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein
    Behloul, Nouredine
    Baha, Sarra
    Shi, Ruihua
    Meng, Jihong
    VIRUS RESEARCH, 2020, 286
  • [43] Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study
    Devi, Arpita
    Chaitanya, Nyshadham S. N.
    MOLECULAR DIVERSITY, 2022, 26 (01) : 157 - 169
  • [44] Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
    Bozdaganyan, Marine E.
    Shaitan, Konstantin V.
    Kirpichnikov, Mikhail P.
    Sokolova, Olga S.
    Orekhov, Philipp S.
    VIRUSES-BASEL, 2022, 14 (02):
  • [45] Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody
    Cao, Xiaoling
    Zai, Junjie
    Zhao, Qingzhen
    Xie, Lilan
    Li, Yaoming
    VACCINE, 2022, 40 (40) : 5757 - 5763
  • [46] Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain
    Sankhala, Rajeshwer S.
    Dussupt, Vincent
    Chen, Wei-Hung
    Bai, Hongjun
    Martinez, Elizabeth J.
    Jensen, Jaime L.
    Rees, Phyllis A.
    Hajduczki, Agnes
    Chang, William C.
    Choe, Misook
    Yan, Lianying
    Sterling, Spencer L.
    Swafford, Isabella
    Kuklis, Caitlin
    Soman, Sandrine
    King, Jocelyn
    Corbitt, Courtney
    Zemil, Michelle
    Peterson, Caroline E.
    Mendez-Rivera, Letzibeth
    Townsley, Samantha M.
    Donofrio, Gina C.
    Lal, Kerri G.
    Tran, Ursula
    Green, Ethan C.
    Smith, Clayton
    de Val, Natalia
    Laing, Eric D.
    Broder, Christopher C.
    Currier, Jeffrey R.
    Gromowski, Gregory D.
    Wieczorek, Lindsay
    Rolland, Morgane
    Paquin-Proulx, Dominic
    van Dyk, Dewald
    Britton, Zachary
    Rajan, Saravanan
    Loo, Yueh Ming
    McTamney, Patrick M.
    Esser, Mark T.
    Polonis, Victoria R.
    Michael, Nelson L.
    Krebs, Shelly J.
    Modjarrad, Kayvon
    Joyce, M. Gordon
    STRUCTURE, 2024, 32 (02) : 131 - 147.e7
  • [47] Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain
    Antonopoulos, Aristotelis
    Broome, Steven
    Sharov, Victor
    Ziegenfuss, Christopher
    Easton, Richard L.
    Panico, Maria
    Dell, Anne
    Morris, Howard R.
    Haslam, Stuart M.
    GLYCOBIOLOGY, 2021, 31 (03) : 181 - 187
  • [48] Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
    Mehalko, Jennifer
    Drew, Matthew
    Snead, Kelly
    Denson, John-Paul
    Wall, Vanessa
    Taylor, Troy
    Sadtler, Kaitlyn
    Messing, Simon
    Gillette, William
    Esposito, Dominic
    PROTEIN EXPRESSION AND PURIFICATION, 2021, 179
  • [49] Peptide Binder with High-Affinity for the SARS-CoV-2 Spike Receptor-Binding Domain
    Yu, Lanlan
    Wang, Ruonan
    Wen, Tao
    Liu, Lei
    Wang, Tao
    Liu, Shuli
    Xu, Haiyan
    Wang, Chenxuan
    ACS APPLIED MATERIALS & INTERFACES, 2022, 14 (25) : 28527 - 28536
  • [50] Infrared spectra of the SARS-CoV-2 spike receptor-binding domain: Molecular dynamics simulations
    Du, Jianbin
    Yao, Ning
    Ma, Xiangyun
    Wang, Huijie
    Li, Qifeng
    Feng, Zhifang
    CHEMICAL PHYSICS LETTERS, 2023, 810